Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection

10.1172/JCI43796

10.1084/jem.179.3.1041

10.1128/JVI.02202-06

10.1084/jem.171.1.231

10.1186/1742-4690-4-57

10.1053/j.gastro.2010.06.047

10.4049/jimmunol.178.4.2572

10.1126/science.1198469

10.1038/nature12331

1996, Transforming growth factor-β1 stimulates degranulation and oxidant release by adherent human neutrophils, J Leukoc Biol, 60, 772, 10.1002/jlb.60.6.772

10.1073/pnas.90.8.3442

10.1126/science.1636092

2008, HIV-1 infection and HIV-1 Tat protein permit the survival and replication of a non-pathogenic trypanosomatid in macrophages through TGF-β1 production, Microbes Infect, 10, 642, 10.1016/j.micinf.2008.02.014

10.1016/j.immuni.2012.08.024

10.1111/imm.12061

10.1084/jem.20120493

1992, IFN-γ and transforming growth factor-β1 differently regulate fibronectin and laminin receptors of human differentiating monocytic cells, J Immunol, 148, 3912

10.1038/ni.2154

10.3899/jrheum.100180

10.1038/nm924

10.1016/j.jhep.2013.07.036

10.1038/ni.3108

10.1128/IAI.01146-10

10.1038/nature04753

10.1016/j.cytogfr.2013.11.001

10.1165/ajrcmb.16.3.9070612

2012, TGF-β blockade does not improve control of an established persistent viral infection, Viral Immunol, 25, 232

10.1053/j.gastro.2006.09.016

10.1084/jem.184.6.2417

10.4049/jimmunol.173.5.3305

1997, Effect of TGF-β1 on cell cycle regulatory proteins in LPS-stimulated normal mouse B lymphocytes, J Immunol, 159, 4155

10.1128/MCB.13.2.1155

1991, Type I transforming growth factor-β receptors on neutrophils mediate chemotaxis to transforming growth factor-β, J Immunol, 147, 1600

10.1038/nri3369

2010, Responding to infection and apoptosis—A task for TH17 cells, Ann NY Acad Sci, 1209, 56, 10.1111/j.1749-6632.2010.05747.x

1989, Transforming growth factor-β1 selectively inhibits IL-3-dependent mast cell proliferation without affecting mast cell function or differentiation, J Immunol, 143, 1591

10.4049/jimmunol.0902316

2010, Transforming growth factor-β: Activation by neuraminidase and role in highly pathogenic H5N1 influenza pathogenesis, PLoS Path, 6, e1001136, 10.1371/journal.ppat.1001136

10.4049/jimmunol.1200402

10.1073/pnas.0730640100

10.1038/mi.2012.96

10.1016/S1074-7613(00)00044-3

1993, Integrin αEβ7 mediates adhesion of T lymphocytes to epithelial cells, J Immunol, 150, 3459

10.1146/annurev-immunol-031210-101317

10.1126/science.1217550

10.1016/j.immuni.2011.12.019

1989, Modulation of cytokine production by transforming growth factor-β, J Immunol, 142, 4295

10.1210/en.135.1.439

10.1126/science.7520605

10.1084/jem.20021170

10.1084/jem.20030152

10.1111/j.1365-2567.2004.02110.x

10.4049/jimmunol.180.11.7327

10.1038/nri3007

10.1038/ni.2293

10.1038/ni1383

10.1084/jem.20130930

10.1111/j.1600-0897.2008.00582.x

10.1084/jem.170.3.1039

10.1084/jem.20070590

10.4049/jimmunol.167.2.773

10.1093/neuonc/nop009

10.1146/annurev-immunol-031210-101400

10.1038/sj.cdd.4402192

2008, Association between transforming growth factor-β1 polymorphism and virologic characteristics of chronic hepatitis C, Transl Res, 152, 151, 10.1016/j.trsl.2008.08.001

10.1038/ni.1677

10.1084/jem.20082286

10.1084/jem.20112339

2014, Transforming growth factor β1 up-regulates CD169 (sialoadhesin) expression on monocyte-derived dendritic cells: Role in HIV sexual transmission, AIDS, 28, 2375, 10.1097/QAD.0000000000000431

10.4049/jimmunol.174.6.3237

10.4049/jimmunol.180.3.1792

10.1084/jem.20090127

10.1073/pnas.1319269111

10.1046/j.1440-1711.2000.00882.x

10.4049/jimmunol.1201937

10.4049/jimmunol.1300199

1992, Effect of transforming growth factor (TGF)-β1 on IgA isotype expression. TGF-β1 induces a small increase in sIgA+ B cells regardless of the method of B cell activation, J Immunol, 148, 3830

10.1084/jem.20041044

10.1016/j.immuni.2012.01.020

10.1189/jlb.0204090

10.1111/j.1600-0897.2006.00432.x

10.1038/nature10228

10.1086/510852

10.1038/sj.emboj.7600085

1992, Transforming growth factor-β1 bifunctionally regulates murine macrophage proliferation, Blood, 79, 1679, 10.1182/blood.V79.7.1679.1679

10.4049/jimmunol.172.9.5149

2009, Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression, Gastroenterology, 136, 1308–1316

10.1084/jem.173.5.1121

10.1002/ibd.21281

10.1038/mi.2010.68

10.1172/JCI200113863

10.1016/j.intimp.2007.07.003

10.1038/ng.717

10.4049/jimmunol.168.2.900

10.1038/nature14452

10.4049/jimmunol.1102389

10.1136/gut.2004.054650

10.1084/jem.187.6.961

1999, TGF-β1 prevents the noncognate maturation of human dendritic Langerhans cells, J Immunol, 162, 4567

10.1084/jem.189.2.231

10.1038/nature09447

10.1038/nri3671

10.1056/NEJMoa0907206

10.4049/jimmunol.174.10.5987

10.1016/S1074-7613(00)80170-3

10.4049/jimmunol.165.9.4773

10.1084/jem.20012076

10.1084/jem.20101074

10.1006/jaut.2002.0599

1994, Transforming growth factor-β1 mediates mast cell chemotaxis, J Immunol, 152, 5860

10.1073/pnas.1108352109

10.1093/intimm/dxh183

10.1016/j.immuni.2011.03.005

10.1074/jbc.274.44.31577

10.1101/cshperspect.a018341

10.1203/00006450-199908000-00012

10.1002/1521-4141(200009)30:9<2639::AID-IMMU2639>3.0.CO;2-7

10.1016/S0188-4409(02)00463-0

10.1146/annurev-immunol-020711-074937

10.1038/ni1451

10.1006/clin.1996.0125

10.4049/jimmunol.1402369

10.1016/j.immuni.2011.02.021

10.4049/jimmunol.1300397

10.1073/pnas.1304498110

10.1016/j.cell.2006.07.035

10.1016/j.chom.2008.09.009

10.1146/annurev.immunol.021908.132657

10.1172/JCI32140

2011, Loss of interleukin-10 or transforming growth factor β signaling in the human colon initiates a T-helper 1 response via distinct pathways, Gastroenterology, 141, 1887–1896

10.1038/ni.2746

1991, Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1, J Immunol, 147, 1792

10.1371/journal.pone.0042268

10.4049/jimmunol.0803320

10.1146/annurev.immunol.25.022106.141623

10.1016/S0091-6749(99)70021-7

10.1371/journal.pmed.0050041

10.1038/mi.2010.42

10.1084/jem.20071401

2014, Important roles played by TGF-β in hepatitis B infection, J Med Virol, 86, 102, 10.1002/jmv.23727

10.1016/j.immuni.2015.06.010

10.1038/85303

1986, Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes, J Immunol, 137, 3855

10.1084/jem.163.5.1037

1991, Transforming growth factor-β suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA, J Immunol, 146, 4016

10.4049/jimmunol.1000981

2012, High serum levels of TGF-β in Iranians with chronic HBV infection, Hepat Mon, 12, e7581

10.4049/jimmunol.172.1.40

1990, Transforming growth factor β1 increases IgA isotype switching at the clonal level, J Immunol, 145, 3773

10.1093/molehr/gah240

10.1016/S1074-7613(00)80565-8

10.1084/jem.20030917

10.4049/jimmunol.176.4.2389

2005, Ca2+ signaling down-regulates TGF-β1 gene expression in CD4+ T cells, Biochem Biophys Res Commun, 327, 494, 10.1016/j.bbrc.2004.12.029

10.1038/ni.1997

10.1146/annurev.immunol.021908.132710

10.1172/JCI200523006

10.1073/pnas.88.7.2918

10.1038/ni.2362

10.1073/pnas.0707421104

10.1038/ni1197

10.1016/S1286-4579(99)00254-3

1990, Mechanism for transforming growth factor β and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures, J Immunol, 144, 952

10.1101/gad.856201

10.4049/jimmunol.172.12.7335

10.1016/j.bbrc.2010.02.094

10.1038/ncomms1469

10.1038/ni.2416

10.1126/science.8009224

10.1038/mi.2013.31

10.1016/j.immuni.2006.07.011

10.1146/annurev.immunol.24.021605.090737

10.1016/j.immuni.2007.03.014

10.1016/j.immuni.2013.07.020

1992, Regulation of transcription of the germ-line Igα constant region gene by an ATF element and by novel transforming growth factor-β1-responsive elements, J Immunol, 149, 2914

10.4049/jimmunol.174.10.5950

10.1053/j.gastro.2008.01.005

10.1038/ni.1607

10.1038/mi.2012.12

10.1093/humrep/14.6.1534

10.1111/j.1749-6632.1993.tb35912.x

10.1083/jcb.124.3.365

10.1084/jem.191.7.1187

10.1158/0008-5472.CAN-04-0896

10.1182/blood-2006-05-025676

10.1046/j.1365-3083.1998.00298.x

10.1038/ni.2744

10.1016/j.immuni.2015.11.008

10.1053/j.gastro.2010.09.043

10.1038/ni.1610

2013, TGF-β signaling manipulation as potential therapy for IBD, Curr Drug Targets, 14, 1400, 10.2174/13894501113149990157

10.1038/ni.2388

10.1016/j.immuni.2006.07.012

10.7554/eLife.04851

10.1074/jbc.C110.155820

10.1095/biolreprod.112.106542

10.1038/ni1539

10.1038/ng.549

10.4049/jimmunol.174.4.2071

10.4049/jimmunol.172.7.4275

10.1038/nri1457

10.1172/JCI43786

1999, A novel function for transforming growth factor-β1: Upregulation of the expression and the IgE-independent extracellular release of a mucosal mast cell granule-specific β-chymase, mouse mast cell protease-1, Blood, 93, 3473, 10.1182/blood.V93.10.3473.410k01_3473_3486

1994, Defective production of anti-inflammatory cytokine, TGF-β by T cell lines of patients with active multiple sclerosis, J Immunol, 152, 6003

10.4049/jimmunol.1002361

10.1172/JCI200112821

10.1053/j.gastro.2005.09.005

10.1038/mi.2008.55

10.1038/mt.2011.290

10.1172/JCI2992

10.1111/j.1600-065X.2011.01002.x

1990, Transforming growth factor β downregulates interleukin-1 (IL-1)-induced IL-6 production by human monocytes, Blood, 76, 2466, 10.1182/blood.V76.12.2466.2466

10.1074/jbc.C400503200

1997, TGF-β attenuates the class II transactivator and reveals an accessory pathway of IFN-γ action, J Immunol, 158, 1095

10.1016/j.crohns.2014.01.013

10.4049/jimmunol.170.11.5563

10.1111/j.1600-0897.1995.tb00897.x

10.1002/eji.200737068

10.1111/j.1399-3038.2009.00913.x

10.1016/j.earlhumdev.2004.01.005

10.4049/jimmunol.1301843

1998, Decreased production of TGF-β by lymphocytes from patients with systemic lupus erythematosus, J Immunol, 160, 2539

10.1191/096120399678847489

2000, Human mast cell migration in response to members of the transforming growth factor-β family, J Leukoc Biol, 67, 350, 10.1002/jlb.67.3.350

10.1084/jem.188.1.39

10.1084/jem.20030713

10.1016/j.immuni.2010.04.012

10.1016/j.immuni.2013.07.016

10.1084/jem.20051496

10.1053/j.gastro.2011.06.076

10.1038/ni.2077

10.1074/jbc.275.5.3552

10.1002/1521-4141(200106)31:6<1706::AID-IMMU1706>3.0.CO;2-Z

10.1016/j.immuni.2004.07.016

10.1038/ni.1840

10.1182/blood-2011-04-346825

10.1016/j.jpeds.2009.11.016

1998, Transforming growth factor-β levels in maternal milk and expression in postnatal rat duodenum and ileum, Pediatr Res, 44, 524, 10.1203/00006450-199810000-00010

2008, Association of TGF-β1 codon 25 (G915C) polymorphism with hepatitis C virus infection, J Med Virol, 80, 58, 10.1002/jmv.21011

10.1002/eji.1830180117

10.1097/QAD.0b013e32836253fd

1998, Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-γ, STAT1, and TGF-β-regulated expression of the class II transactivator gene, J Immunol, 160, 233

1994, Regulation of intestinal epithelial barrier function by TGF-β1. Evidence for its role in abrogating the effect of a T cell cytokine, J Immunol, 153, 5730

10.1002/(SICI)1097-4652(199910)181:1<55::AID-JCP6>3.0.CO;2-M

10.1186/1742-4690-3-37

10.1038/ni.2292

10.3109/09513599609012815

10.1038/ni0311-189

10.1111/j.1399-3038.2006.00395.x

1991, Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1, J Immunol, 146, 3012

10.4049/jimmunol.1201029

10.1002/eji.201041135

10.1097/MPG.0b013e31823e7c29

10.1177/096120339500400409

10.1073/pnas.88.15.6805

1999, HIV-1 Tat: Immunosuppression via TGF-β1 induction, Immunol Today, 20, 384, 10.1016/S0167-5699(99)01497-8

10.1038/ni.2518

10.1007/s00441-005-1127-3

10.1101/cshperspect.a021907

10.1016/S0165-0378(02)00015-3

10.1095/biolreprod.108.074658

10.1016/j.jri.2009.08.003

10.1111/aji.12107

10.4049/jimmunol.179.1.71

10.1111/j.0105-2896.2009.00886.x

10.4049/jimmunol.169.10.5689

10.1016/j.cell.2007.10.034

10.4049/jimmunol.181.7.4485

10.1038/nature11462

1990, Regulatory effects of transforming growth factor-β on IL-2- and IL-4-dependent T cell-cycle progression, J Immunol, 144, 1767

1997, Lymphotactin gene expression in mast cells following Fcɛ receptor I aggregation: Modulation by TGF-β, IL-4, dexamethasone, and cyclosporin A, J Immunol, 158, 1353

10.1038/ni.2134

2000, Breast-feeding and the development of cows’ milk protein allergy, Adv Exp Med Biol, 478, 121

1993, Transforming growth factor-β (TGF-β) in human milk, Clin Exp Immunol, 94, 220

10.4049/jimmunol.1201966

10.1016/j.cell.2012.05.031

10.1016/j.immuni.2009.04.020

10.1016/S0165-5728(98)00044-7

10.1016/j.immuni.2014.12.007

10.1084/jem.20112646

10.1038/ni.2947

2009, Plasmodium falciparum-mediated induction of human CD25hiFoxp3hi CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFβ, PLoS Path, 5, e1000543, 10.1371/journal.ppat.1000543

1999, Mucosal T lymphocyte numbers are selectively reduced in integrin αE (CD103)-deficient mice, J Immunol, 162, 6641

10.1186/ar1039

1996, Influenza virus neuraminidase activates latent transforming growth factor β, J Virol, 70, 8624, 10.1128/JVI.70.12.8624-8629.1996

2007, A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-β, J Immunol, 179, 11

10.1084/jem.20051725

10.1038/cmi.2012.72

2011, Stromal down-regulation of macrophage CD4/CCR5 expression and NF-κB activation mediates HIV-1 non-permissiveness in intestinal macrophages, PLoS Path, 7, e1002060, 10.1371/journal.ppat.1002060

10.1016/j.immuni.2014.03.007

10.1111/imr.12160

1998, CBFα3 (AML2) is induced by TGF-β1 to bind and activate the mouse germline Igα promoter, J Immunol, 161, 6751

1991, Effect of cytokines on switching to IgA and α germline transcripts in the B lymphoma I.29µ. Transforming growth factor-β activates transcription of the unrearranged Cα gene, J Immunol, 147, 4374

10.1046/j.1365-2567.2001.01185.x

10.1084/jem.174.3.539

10.1016/j.immuni.2012.08.008

10.1038/ni.2745

10.1371/journal.pbio.1001674

1996, Transforming growth factor-β1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium, J Immunol, 157, 360

10.1084/jem.194.9.1253

10.1172/JCI200519229

10.1189/jlb.1005566

10.1084/jem.170.4.1415

10.4049/jimmunol.181.8.5510

10.1002/eji.200939684

2012, Absence of signaling into CD4+ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3+ regulatory T cells, Nat Immunol, 14, 162

10.1146/annurev-immunol-020711-075035

1996, TGF-β1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors, J Immunol, 157, 1499

1991, A role for transforming growth factor-β1 in regulating natural killer cell and T lymphocyte proliferative responses during acute infection with lymphocytic choriomeningitis virus, J Immunol, 147, 2717

1993, Transforming growth factor-β expression and natural killer cell responses during virus infection of normal, nude, and SCID mice, J Immunol, 151, 4874

10.1084/jem.20070602

10.1371/journal.ppat.1002594

10.1016/S1567-5769(02)00276-X

10.1093/intimm/14.4.339

1994, Transforming growth factors β1, β2, and β3 messenger RNA and protein expression in mouse uterus and vagina during estrogen-induced growth: A comparison to other estrogen-regulated genes, Cell Growth Differ, 5, 919

10.4049/jimmunol.0904100

10.4049/jimmunol.1301276

10.1182/blood-2006-11-056010

10.1073/pnas.89.16.7375

10.1016/j.immuni.2009.06.015

10.1038/ni1549

10.1038/nature07781

10.1073/pnas.0901944106

10.1146/annurev-immunol-032713-120257

10.1038/nature06110

10.1016/1043-4666(90)90018-O

10.1038/ni730

1992, Transforming growth factor-β directs IgA switching in human B cells, J Immunol, 148, 2062

10.1016/j.immuni.2006.01.001

10.1038/ni1391

10.1016/j.coi.2010.08.008

10.1038/nm1718

10.1073/pnas.84.16.5788

10.1084/jem.173.4.981

10.1084/jem.177.1.225

10.1073/pnas.90.10.4577

10.1016/j.immuni.2005.08.006

10.4049/jimmunol.167.6.3360

10.1073/pnas.0901965106

10.1091/mbc.E11-12-1018

10.4049/jimmunol.1300433

1992, Anti-immunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor β but pRB hypophosphorylation is transforming growth factor β independent, Cell Growth Differ, 3, 175

10.1073/pnas.0703642104

10.1034/j.1600-065X.2001.1820117.x

10.1089/088282404322875502

10.1016/1074-7613(95)90145-0

10.1046/j.1365-2567.2003.01670.x

10.1210/en.143.8.2872

10.4049/jimmunol.173.5.3093

10.1053/j.gastro.2011.06.057

10.1038/ni.2390

10.1016/j.immuni.2010.09.001

10.4049/jimmunol.166.12.7282

10.1002/stem.150144

10.1093/emboj/18.5.1280

10.1038/nature07021

10.1016/j.immuni.2006.03.016

10.4049/jimmunol.1101880

1992, tat protein stimulates production of transforming growth factor-β1 by marrow macrophages: A potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression, Blood, 80, 3036, 10.1182/blood.V80.12.3036.3036

10.1007/s00281-006-0023-6

10.1172/JCI45157

10.1038/ni.2319

10.1016/j.immuni.2013.08.019

10.1074/jbc.M001526200

1999, Localization of transforming growth factor-β receptor types I, II, and III in the postnatal rat small intestine, Pediatr Res, 46, 657, 10.1203/00006450-199912000-00017

1999, Transforming growth factor-β1 polarizes murine hematopoietic progenitor cells to generate Langerhans cell-like dendritic cells through a monocyte/macrophage differentiation pathway, Blood, 93, 1208, 10.1182/blood.V93.4.1208

10.1210/jc.79.4.1177

10.4049/jimmunol.1102918

10.1038/nature08750

1998, Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-α plays a critical role in maintaining secondary immunity in the absence of IFN-γ, J Immunol, 160, 1359

10.1038/ni1488

10.1038/nature06878

10.1084/jem.20081666